E-LIB Suche - Ergebnisse für: Paola Cavalla

1

P-310/1296/Quality of Life in Patients and Caregivers with ..:

Augusto Gauthier ; Paola Cavalla ; Federica Plano...
Quality of Life Research. 14 (2005) 9 - p. 2137 ff. , 2005

Link: https://www.jstor.org/st..

2

Long-term effectiveness of natalizumab in secondary progres..:

Chisari, Clara G. ; Aguglia, Umberto ; Amato, Maria Pia...
Neurotherapeutics. 21 (2024) 4 - p. e00363 , 2024

Link: https://doi.org/10.1016/..

3

A comparison of natalizumab and ocrelizumab on disease prog..:

Iaffaldano, Pietro ; Lucisano, Giuseppe ; Guerra, Tommaso...
Annals of Clinical and Translational Neurology. 11 (2024) 8 - p. 2008-2015 , 2024

Link: https://doi.org/10.1002/..

4

iDPP@CLEF 2024: The Intelligent Disease Progression Predict..:

, In: Lecture Notes in Computer Science; Advances in Information Retrieval,

Aidos, Helena ; Bergamaschi, Roberto ; Cavalla, Paola... - p. 53-59 , 2024

Link: https://doi.org/10.1007/..

5

Impact of COVID-19 on pregnancy and fetal outcomes in women..:

Aprea, Maria Grazia ; Schiavetti, Irene ; Portaccio, Emilio...
Multiple Sclerosis Journal. 30 (2024) 6 - p. 707-713 , 2024

Link: https://doi.org/10.1177/..

6

Identifying definite patterns of unmet needs in patients wi..:

Maida, Elisabetta ; Abbadessa, Gianmarco ; Cocco, Eleonora...
Neurological Sciences. 45 (2024) 7 - p. 3333-3345 , 2024

Link: https://doi.org/10.1007/..

7

Association of MRI leptomeningeal enhancement with disabili..:

Vercellino, Marco ; Costantini, Gianfranco ; Cogoni, Maurizio...
Multiple Sclerosis Journal. 29 (2023) 13 - p. 1526-1539 , 2023

Link: https://doi.org/10.1177/..

8

Symptomatic COVID-19 course and outcomes after three mRNA v..:

Capuano, Rocco ; Prosperini, Luca ; Altieri, Manuela...
Multiple Sclerosis Journal. 29 (2023) 7 - p. 856-865 , 2023

Link: https://doi.org/10.1177/..

9

iDPP@CLEF 2023: The Intelligent Disease Progression Predict..:

, In: Lecture Notes in Computer Science; Advances in Information Retrieval,

Aidos, Helena ; Bergamaschi, Roberto ; Cavalla, Paola... - p. 491-498 , 2023

Link: https://doi.org/10.1007/..

10

SARS-CoV-2 pandemic as a model to assess the relationship b..:

Vercellino, Marco ; Bosa, Chiara ; Alteno, Anastasia...
Multiple Sclerosis and Related Disorders. 74 (2023) - p. 104715 , 2023

Link: https://doi.org/10.1016/..

11

Quality of care provided by Multiple Sclerosis Centers duri..:

Altieri, Manuela ; Capuano, Rocco ; Bisecco, Alvino...
Multiple Sclerosis and Related Disorders. 77 (2023) - p. 104870 , 2023

Link: https://doi.org/10.1016/..

12

Evaluation of drivers of treatment switch in relapsing mult..:

Iaffaldano, Pietro ; Lucisano, Giuseppe ; Guerra, Tommaso...
Journal of Neurology. 271 (2023) 3 - p. 1150-1159 , 2023

Link: https://doi.org/10.1007/..

13

Effectiveness of Ocrelizumab in Primary Progressive Multipl..:

Chisari, Clara G. ; Bianco, Assunta ; Brescia Morra, Vincenzo...
Neurotherapeutics. 20 (2023) 6 - p. 1696-1706 , 2023

Link: https://doi.org/10.1007/..

14

Prevalence of Multiple Sclerosis in Patients with Inflammat..:

Perez-Diaz-del-Campo, Nuria ; Caviglia, Gian Paolo ; Piana, Giorgia La...
Gastrointestinal Disorders. 5 (2023) 3 - p. 287-295 , 2023

Link: https://doi.org/10.3390/..

15

Effectiveness of teriflunomide on No Evidence of Disease Ac..:

Amato, Maria Pia ; Bergamaschi, Roberto ; Centonze, Diego...
Journal of Neurology. 270 (2023) 10 - p. 4687-4696 , 2023

Link: https://doi.org/10.1007/..